Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Latest filing published 07 Apr 2026 for Replimune Group, Inc..
Filing timeline
BuySaleChristopher Sarchi
Insider track record
Disclosed buys
0
Disclosed sells
6
Signal history
Christopher Sarchi: trading record in brief
All filings by Christopher Sarchi on record concern Replimune Group, Inc. We count 10 filings; the first trade dates from 16 November 2023 and the latest from 2 April 2026.
Every open-market trade on record is a sale: 6 sales worth €232k. Outside the open market, there are 4 share grants. Since January 2026: no purchases and 1 sale on the market.
The latest filing, published on 7 April 2026, reports a share grant in Replimune Group, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Christopher Sarchi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
50,000 shares0Common StockSEC:0001104659-26-040579:0
6,500 shares@ US$8.0119.4% of flowCommon StockSEC:0001104659-26-039967:0
35,000 shares0Common StockSEC:0001104659-25-123282:0
5,208 shares@ US$9.1017.6% of flowCommon StockSEC:0001104659-25-114124:0
3,749 shares@ US$8.0511.5% of flowCommon StockSEC:0001104659-25-052140:0
45,000 shares0Common StockSEC:0001104659-25-031826:0
5,207 shares@ US$10.7823.0% of flowCommon StockSEC:0001104659-24-121187:0
2,218 shares@ US$6.475.7% of flowCommon StockSEC:0001104659-24-063564:0
22,225 shares0Common StockSEC:0001104659-24-043250:0
5,255 shares@ US$10.9222.8% of flowCommon StockSEC:0001104659-23-119645:0
10 of 10 declarations
